Across social media and encrypted messaging apps, a new frontier of weight loss is unfolding in real time, with people ...

HE was a devoted granddad, always running around playing with his grandkids when he wasn’t working or out socialising. That ...

Social media advertisements of weight-loss drugs such as Wegovy and Mounjaro is illegal as per the India law, lawyers tell ...

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...

Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as 100,000+ Patients ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.

Novo Nordisk trades 32% below fair value with a 3.6% yield, semaglutide at 74% of sales, EPS rebound post '26, and pipeline ...

Eli Lilly has now submitted a new drug application (NDA) for GLP-1RA orforglipron to the FDA for use in adults with obesity.

Thousands of Australians would get access to a popular weight-loss jab on the PBS to treat obesity, under a proposal green lit by an independent government committee.

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

Thousands of Australians would get access to a popular weight-loss jab on the PBS to treat obesity, under a proposal green ...